Clinical Trials · NCT06946628
New Triple Therapy in Newly Diagnosed Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Sun Yat-sen University
- Enrollment
- 296
- Start date
- Jun 2025
- Locations
- 1 site, China
- Primary endpoint
- Diabetic remission rate